Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Successful treatment of extensively drug-resistant Pseudomonas aeruginosa osteomyelitis using a colistin- and tobramycin-impregnated PMMA spacer.
Krajewski J, Bode-Böger SM, Tröger U, Martens-Lobenhoffer J, Mulrooney T, Mittelstädt H, Russlies M, Kirchner R, Knobloch JK. Krajewski J, et al. Among authors: mulrooney t. Int J Antimicrob Agents. 2014 Oct;44(4):363-6. doi: 10.1016/j.ijantimicag.2014.05.023. Epub 2014 Aug 13. Int J Antimicrob Agents. 2014. PMID: 25182711
Durvalumab Treatment Patterns for Patients with Unresectable Stage III Non-Small Cell Lung Cancer in the Veterans Health Administration (VHA): A Nationwide, Real-World Study.
Moore AM, Nooruddin Z, Reveles KR, Datta P, Whitehead JM, Franklin K, Alkadimi M, Williams MH, Williams RA, Smith S, Reichelderfer R, Cotarla I, Brannman L, Frankart A, Mulrooney T, Hsieh K, Simmons DJ, Jones X, Frei CR. Moore AM, et al. Among authors: mulrooney t. Curr Oncol. 2023 Sep 13;30(9):8411-8423. doi: 10.3390/curroncol30090611. Curr Oncol. 2023. PMID: 37754526 Free PMC article.
Health Equity in Patients Receiving Durvalumab for Unresectable Stage III Non-Small Cell Lung Cancer in the US Veterans Health Administration.
Moore AM, Nooruddin Z, Reveles KR, Koeller JM, Whitehead JM, Franklin K, Datta P, Alkadimi M, Brannman L, Cotarla I, Frankart AJ, Mulrooney T, Jones X, Frei CR. Moore AM, et al. Among authors: mulrooney t. Oncologist. 2023 Sep 7;28(9):804-811. doi: 10.1093/oncolo/oyad172. Oncologist. 2023. PMID: 37335901 Free PMC article.
31 results